Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Eur J Med Chem. 2020 Jan 24;190:112085. doi: 10.1016/j.ejmech.2020.112085

Table 2.

Early and late stage infection results of control PF-74 and 6a-9 against HIV-1NL4-3 single-round infectious pseudoviruses.

Compound Early Stage IC50
(μM)
Late Stage IC50
(μM)
PF-74 0.056 ± 0.017 0.23 ± 0.17
6a-9 8.18 ± 1.80 0.32 ± 0.11